| Patent Number | Grant Date | Title | Applicant |
|---|---|---|---|
| EP2736487 | Aug 28, 2024 | New (Trimethoxyphenylamino)Pyrimidinyl Formulations | RIGEL PHARMACEUTICALS, INC. |
| EP2464337 | Jun 26, 2024 | Pharmaceutical Composition And Administrations Thereof | VERTEX PHARMACEUTICALS INC. |
| EP4084799 | Apr 17, 2024 | Use Of Nmn For The Prevention And/Or Treatment Of Joint Pain Induced By Physical Activity, And Corresponding Compositions | NUVAMID SA |
| EP3293202 | Feb 7, 2024 | Anti Human Interleukin-1 Receptor Accessory Protein (Il1Rap) Antibodies And Uses Thereof | CANTARGIA AB |
| EP2679681 | Nov 15, 2023 | Fc Riib-Specific Fc Antibody | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| EP3432890 | Jul 12, 2023 | Product, In Particular Nutritional Supplement, Animal Feed, Foodstuff, Drug, Cosmetic And/Or Animal Feed Supplement For Supplying At Least One Molecule That Bonds To A Vitamin D Receptor, And Method For The Production Thereof | BÜTER, BERND |
| EP3485890 | May 10, 2023 | Treatment Of Metabolic Disorders In Canine Animals | BOEHRINGER INGELHEIM VETMEDICA GMBH |
| EP3302437 | Dec 21, 2022 | Stable Cannabinoid Formulations | FRESH CUT DEVELOPMENT, LLC |
| EP3738585 | Dec 14, 2022 | Direct Compression Formulation And Process | NOVARTIS AG |
| EP3516966 | Nov 30, 2022 | A Concentrated Krill Protein Hydrolysate Fraction | RIMFROST TECHNOLOGIES AS |
| Patent Number | Grant Date | Title | Applicant | Facing Oppositions |
|---|---|---|---|---|
| EP3204047 | May 27, 2020 | Calcifediol Soft Capsules | FAES FARMA, S.A. | 12 |
| EP3366283 | Sep 1, 2021 | Direct Compression Formulation And Process | NOVARTIS AG | 12 |
| EP2397142 | Jul 27, 2022 | Use Of Dpp Iv Inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | 10 |
| EP3293202 | Feb 7, 2024 | Anti Human Interleukin 1 Receptor Accessory Protein (Il1rap) Antibodies And Uses Thereof | CANTARGIA AB | 9 |
| EP3345607 | Oct 26, 2022 | Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or Agonist | OSTEOQC INC. | 8 |
| EP2968155 | Mar 3, 2021 | Tofacitinib Oral Sustained Release Dosage Forms | PFIZER INC. | 6 |
| EP3403646 | Sep 28, 2022 | Liquid Pharmaceutical Composition | FRESENIUS KABI DEUTSCHLAND GMBH | 6 |
| EP2345668 | Sep 22, 2021 | Sclerostin Epitopes | AMGEN, INC. | 6 |
| EP2464337 | Jun 26, 2024 | Pharmaceutical Composition And Administrations Thereof | VERTEX PHARMACEUTICALS INCORPORATED | 4 |
| EP3085386 | Jun 24, 2020 | Method For Inhibiting Bone Resorption | AMGEN INC. | 4 |
Feel free to send us a message here and we will get back to you